描述腹癌中的免疫环境:对新型免疫疗法策略的见解

Patrick L Wagner1, Chelsea M Knotts2, Vera S Donneberg3,4

  • 1Division of Surgical Oncology, Allegheny Health Network Cancer Institute, Allegheny Health Network, Pittsburgh, PA, USA. patrick.wagner@ahn.org.

Annals of surgical oncology
|November 23, 2023
PubMed
概括

腹癌与 IL-6 和 IL-8 等促炎媒介体的增加有关,这表明潜在的免疫治疗点. 免疫环境有利于天生的免疫力,阻碍抗瘤反应.